When Immunotherapy Works Even With Low PD-L1 Expression
While PD-L1 testing is widely used to guide immunotherapy decisions, a low or negative PD-L1 result does not necessarily mean […]
Precision Oncology
Precision Oncology
What Is Biomarker-Driven Therapy in Modern Oncology?
Biomarker-driven therapy is a precision oncology approach where cancer treatment is selected based on specific molecular characteristics of a tumor
Disease-Specific Deep Dives
Molecular Subtypes Across Common Cancers: Why Biology Matters More Than Stage
Cancer stage describes where the disease has spread. Molecular subtypes in cancer explains how the cancer behaves. In modern oncology,